2Romagnani P,Rotondi M,Lazzeri E,et al.Expression of CXCL10/CX CL10 and MIG/CXCL9 in the thyroid an d increased levels of IP10/CXCLIO in the serum of patients with recent-onset Graves disease[J].Am J Pathol,2002,161(1):195-206.
3Antonelli A,Fallahi P,Rotondi M,et al.Increased serum CXCL10 in Graves' disease or autoimmune thyroiditis is not associated with hyper-or hypothyroidism perse,but is specifically sustained by the autoimmune,inflammatory process[J].Eur J Endocrinol,2006,154(5):651-658.
4Crescioli C,Cesmi L,Borgogni E,et al.Methimazole inhibits CXC chemokine ligand 10 secretion in human thyrocytes[J].J Endocrinol,2007,195(1):145-155.
5Weetman AP.Autoimmune thyroid disease:propagation and progression[J].Eur J Endocrinol,2003,148(1):1-9.
6Antonelli A,Fallahi P.Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves'disease,and modulation bymethimazole therapy and thyroidectomy[J].Br J Surg,2006,93(10):1226-1231.
7Gianoukakis AG,Douglas RS,King CS,et al.Immunoglobulin G from patients with Graves' disease induces interleukin-16 and RANTES expression in cultured human thyrocytes:a putative mechanism for T-cell infiltration of the thyroid in autoimmune disease[J].Endocrinology,2006,147(4):1941-1949.
4Inukai Y,Momobayashi A,Sugawara N. Changes in expression of T-helper (Th) 1-and Th2-associated chemokine receptors on peripheral blood lymphocytes and plasma concentrations of their ligands,interferon-inducible protein-10 and thymus and activation-regulated chemokine,after antithyroid drug administration in hyperthyroid patients with Graves′ disease[J].{H}European Journal of Endocrinology,2007,(06):623-630.
5Crescioli C,Cosmi L,Borgogni E. Methimazole inhibits CXC chemokine ligand 10 secretion in human thyrocytes[J].{H}Journal of Endocrinology,2007,(01):145-155.
